New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review

P. aeruginosa is still one of the most threatening pathogens responsible for serious hospital-acquired infections. It is intrinsically resistant to many antimicrobial agents and additional acquired resistance further complicates the management of such infections. High rates of combined antimicrobial...

Descripción completa

Detalles Bibliográficos
Autores principales: Losito, Angela Raffaella, Raffaelli, Francesca, Del Giacomo, Paola, Tumbarello, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137685/
https://www.ncbi.nlm.nih.gov/pubmed/35625223
http://dx.doi.org/10.3390/antibiotics11050579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137685/
https://www.ncbi.nlm.nih.gov/pubmed/35625223
http://dx.doi.org/10.3390/antibiotics11050579

Ejemplares similares